Navigation Links
New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
Date:11/1/2008

rial with the general applicability of a 'real-world' study, since it included all patients at our clinic who initiated hepatitis C treatment and met basic eligibility criteria," said Professor Colombo. "The results from this study prove that treatment success rates in the real world can be comparable to those achieved in clinical trials. The study also demonstrates that PEGASYS regimens enable significantly more patients to achieve a SVR."

PEGASYS has demonstrated efficacy in a broad range of patient types, even those with poor prognostic factors.(2)(3)(4)(5)(6)

About Hepatitis C

Hepatitis C is a blood-borne infectious disease of the liver and a leading cause of cirrhosis, liver cancer and the need for liver transplants. According to the Centers for Disease Control and Prevention (CDC), an estimated 4.1 million Americans (1.6 percent) have been infected with hepatitis C; 3.2 million are chronically infected. The number of new infections per year has declined from an average of 240,000 in the 1980s to about 26,000 in 2004. CDC estimates the number of hepatitis C-related deaths could increase to 38,000 annually by the year 2010, surpassing annual HIV/AIDS deaths.

About PEGASYS

PEGASYS, in combination with COPEGUS (ribavirin), is indicated for the treatment of adults with chronic hepatitis C who have compensated liver disease and have not previously been treated with interferon alpha. Efficacy has been demonstrated in patients with compensated liver disease and histological evidence of cirrhosis (Child-Pugh class A) and patients with HIV disease that are clinically stable (e.g., antiretroviral therapy not required or receiving stable antiretroviral therapy). In addition, PEGASYS in combination with COPEGUS is the first and only FDA-approved regimen for the treatment of chronic hepatitis C in patients coinfected with hepatitis C and HIV. PEGASYS is the only pegylated interferon indicated for the treatment of adult patients with chroni
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New International Study Shows Women With Symptomatic Fibroids Delaying Treatment Despite Substantial Burden on Quality of Life
2. Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD
3. Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
4. Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds
5. NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation
6. Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference
7. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
8. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
9. Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults
10. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
11. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013   National Community Pharmacists Association ... RPh, MBA issued the following statement today regarding a ... Part D "preferred pharmacy" drug plans , which ... plan,s lowest advertised co-payments: (Logo:  http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ... and MedPAC , 16 U.S. Senators ...
(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- Today at ... Christine Ginocchio discussed Specific ... for rapid identification of microorganisms producing bloodstream infection. ... Chief of the Division of Infectious Disease Diagnostics ... largest not-for-profit, non-sectarian health system. (Photo: ...
(Date:5/20/2013)... -- Hill-Rom Holdings, Inc. (NYSE: HRC ) invites ... 38 th Annual Deutsche Bank Health Care Conference ... 2013, at 1:30 p.m. EDT. (Logo: ... listen to the live discussion via the internet link ... http://www.media-server.com/m/p/f7bj3q84 . A recorded replay of the discussion ...
Breaking Medicine Technology:Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3
... 2011 Nopras Technologies, Inc., a ... services for organizations in the Pharmaceutical, Biotechnology, Medical ... January 10th, 2011 that it has achieved ... well documented procedures and processes, its proactive response, ...
... 10, 2011 Drawing attention to its TemporalScanner™ Temporal ... "game-time temperature" for national radio broadcasts of NFL games ... The "Exergen Game Time Temperature" promotion is the only ... Night Football and Monday Night Football regular season games, ...
Cached Medicine Technology:Nopras Technologies, Inc. Achieves ISO 9001:2008 Certification 2Exergen TemporalScanner Sponsors 'Game Time Temperature' for NFL and College Bowl Games 2
(Date:5/20/2013)... 20, 2013 When a shopper decides to ... part of the process. Much of the stress and concern ... not knowing what to expect. Best Mattress Online, a ... use to ensure their purchase proves smooth. , In the ... Mattress Online ”, readers find helpful tips divided into two ...
(Date:5/20/2013)... Fastcare Miami Beach clinic advises patients to ... symptoms, as if not treated, it may involve the ureter ... a urinary tract infection in itself is not life threatening, ... called pyelonephritis. Women seem to have many more urinary tract ... percentage as women after the age of fifty. , ...
(Date:5/20/2013)... Los Angeles, CA (PRWEB) May 20, 2013 ... has just been released to the public creating ... to gain access to this elite business training. ... the course as well as an exclusive bonus. ... known for providing elite business training to individuals ...
(Date:5/20/2013)... 20, 2013 Leading facial plastic surgeon and ... as a “Top Doc” in the field of Otolaryngology in ... , The Palm Beacher magazine, one of Palm Beach County’s ... in the May/June 2013 issue, including 70 of the very ... dining, events, things to do, health and fitness, people to ...
(Date:5/20/2013)... The Environmental Design Research ... of continuing education credit opportunities for design professionals, ... Architects Continuing Education System (AIA/CES), the Landscape Architecture ... Design Continuing Education Council (IDCEC). EDRA44Providence ... at the Omni Providence Hotel in Providence, Rhode ...
Breaking Medicine News(10 mins):Health News:See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online 2Health News:Fastcare Advises on How to Prevent a UTI 2Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2Health News:Environmental Design Research Conference to Feature AIA/CES, LA CES, and IDCEC Continuing Education Credits 2
... Consortium, a group of researchers, clinicians and families dedicated ... autism, announced today that it has completed the first ... Autism Gene Discovery Project and has released the reference ... the world can use. The scan was conducted ...
... (Chicago, IL, October 22, 2007) Hospitalized patients who ... the use of hypnotherapy than patients using other smoking ... the 73rd annual international scientific assembly of the American ... who participated in one hypnotherapy session were more likely ...
... Bayer Consumer Care announces,the availability of the ... Sinus), combining a long-lasting nasal decongestant with the,pain-relieving ... from,multiple sinus and pain symptoms. The combination ... in a recent survey of adults who suffer ...
... upon its impressive past,successes, the Midwest Orthopaedic Research ... will propel it forward in the coming decade. ... product,innovation, will solidify MORF as a world-class research ... MORF will be restructuring the board of directors,and ...
... Mind,s emotion centers less controlled when weary, MRI study shows ... little testy after a bad night,s sleep? Scientists may ... lack of sleep causes the brain,s emotional centers to dramatically ... lobe -- a brain region that normally keeps emotions under ...
... annual awards recognize technology innovation for healthcare., ... Healthcare Users Group (MS-HUG) and Microsoft Corp. today,announced ... Healthcare Innovation,Awards. The contest, open to any healthcare ... improve the quality and delivery of,healthcare. (Logo: ...
Cached Medicine News:Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 2Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 3Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 4Health News:Hypnosis for smoking cessation sees strong results 2Health News:ALEVE-D(R) Sinus & Cold Offers Option for the More Than 50% of Consumers Not Satisfied with Current Sinus Medication 2Health News:ALEVE-D(R) Sinus & Cold Offers Option for the More Than 50% of Consumers Not Satisfied with Current Sinus Medication 3Health News:Sleepless Nights Make for Grumpier Brains 2Health News:Call for Entries Announced for 2008 MS-HUG Innovation Awards 2Health News:Call for Entries Announced for 2008 MS-HUG Innovation Awards 3
... Ergonomic Design for Unparalleled Comfort Pick ... Notice the balance. Notice the trigger and ejector ... Thats because our pipettors are ergonomically designed to ... hours of pipetting. Productivity In The Palm ...
... Ergonomic Design for Unparalleled Comfort ... it. Notice the balance. Notice the trigger and ... left-handed. Thats because our pipettors are ergonomically designed ... long hours of pipetting. Productivity In The ...
... The Finnpipette BioControl multichannel ... features as the single ... handle fits all seven ... channel tip cone modules. ...
... , The new Finnpipette Novus is so user-friendly that ... few minutes. With the intuitive instantly familiar menu and ... functions you need quickly and easily. The large, clear ... names of all functions. The easily accessible two ...
Medicine Products: